Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 127 entries
Sorted by: Best Match Show Resources per page
Diagnostic Performance of a Saliva Urea Nitrogen Dipstick to Detect Kidney Disease in Malawi.

Kidney international reports

Evans R, Calice-Silva V, Raimann JG, Hemmila U, Craik A, Mtekateka M, Hamilton F, Kawale Z, Dobbie H, Dreyer G, Levin N, Kotanko P, Pecoits-Filho R.
PMID: 29142958
Kidney Int Rep. 2016 Dec 31;2(2):219-227. doi: 10.1016/j.ekir.2016.12.006. eCollection 2017 Mar.

INTRODUCTION: Kidney disease (KD), including acute kidney injury, is common, severe and leads to significant mortality in the developing world. However, simple tools to facilitate diagnosis and guide treatment are lacking. We studied the diagnostic performance of saliva urea...

Cite
Evans R, Calice-Silva V, Raimann JG, et al. Diagnostic Performance of a Saliva Urea Nitrogen Dipstick to Detect Kidney Disease in Malawi. Kidney Int Rep. 2016;2(2):219-227doi: 10.1016/j.ekir.2016.12.006.
Evans, R., Calice-Silva, V., Raimann, J. G., Hemmila, U., Craik, A., Mtekateka, M., Hamilton, F., Kawale, Z., Dobbie, H., Dreyer, G., Levin, N., Kotanko, P., Pecoits-Filho, R. (2017). Diagnostic Performance of a Saliva Urea Nitrogen Dipstick to Detect Kidney Disease in Malawi. Kidney international reports, 2(2), 219-227. https://doi.org/10.1016/j.ekir.2016.12.006
Evans, Rhys, et al. "Diagnostic Performance of a Saliva Urea Nitrogen Dipstick to Detect Kidney Disease in Malawi." Kidney international reports vol. 2,2 (2017): 219-227. doi: https://doi.org/10.1016/j.ekir.2016.12.006
Evans R, Calice-Silva V, Raimann JG, Hemmila U, Craik A, Mtekateka M, Hamilton F, Kawale Z, Dobbie H, Dreyer G, Levin N, Kotanko P, Pecoits-Filho R. Diagnostic Performance of a Saliva Urea Nitrogen Dipstick to Detect Kidney Disease in Malawi. Kidney Int Rep. 2016 Dec 31;2(2):219-227. doi: 10.1016/j.ekir.2016.12.006. eCollection 2017 Mar. PMID: 29142958; PMCID: PMC5678625.
Copy Download .nbib Format: NLM
Indirect Costs of Diabetes Mellitus (Dm) From the Perspective of The Social Insurance Institution (Zus) In Poland.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Kawalec P.
PMID: 27200624
Value Health. 2014 Nov;17(7):A340. doi: 10.1016/j.jval.2014.08.673. Epub 2014 Oct 26.

No abstract available.

Cite
Kawalec P. Indirect Costs of Diabetes Mellitus (Dm) From the Perspective of The Social Insurance Institution (Zus) In Poland. Value Health. 2014;17(7):A340doi: 10.1016/j.jval.2014.08.673.
Kawalec, P. (2014). Indirect Costs of Diabetes Mellitus (Dm) From the Perspective of The Social Insurance Institution (Zus) In Poland. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17(7), A340. https://doi.org/10.1016/j.jval.2014.08.673
Kawalec, P. "Indirect Costs of Diabetes Mellitus (Dm) From the Perspective of The Social Insurance Institution (Zus) In Poland." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17,7 (2014): A340. doi: https://doi.org/10.1016/j.jval.2014.08.673
Kawalec P. Indirect Costs of Diabetes Mellitus (Dm) From the Perspective of The Social Insurance Institution (Zus) In Poland. Value Health. 2014 Nov;17(7):A340. doi: 10.1016/j.jval.2014.08.673. Epub 2014 Oct 26. PMID: 27200624.
Copy Download .nbib Format: NLM
Costs of Absenteeism In Ankylosing Spondylitis Based On Real-Life Data From Poland's Social Insurance Institution Database In 2012.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Malinowski K, Kawalec P.
PMID: 27201676
Value Health. 2014 Nov;17(7):A529. doi: 10.1016/j.jval.2014.08.1674. Epub 2014 Oct 26.

No abstract available.

Cite
Malinowski K, Kawalec P. Costs of Absenteeism In Ankylosing Spondylitis Based On Real-Life Data From Poland's Social Insurance Institution Database In 2012. Value Health. 2014;17(7):A529doi: 10.1016/j.jval.2014.08.1674.
Malinowski, K., & Kawalec, P. (2014). Costs of Absenteeism In Ankylosing Spondylitis Based On Real-Life Data From Poland's Social Insurance Institution Database In 2012. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17(7), A529. https://doi.org/10.1016/j.jval.2014.08.1674
Malinowski, K, and Kawalec, P. "Costs of Absenteeism In Ankylosing Spondylitis Based On Real-Life Data From Poland's Social Insurance Institution Database In 2012." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17,7 (2014): A529. doi: https://doi.org/10.1016/j.jval.2014.08.1674
Malinowski K, Kawalec P. Costs of Absenteeism In Ankylosing Spondylitis Based On Real-Life Data From Poland's Social Insurance Institution Database In 2012. Value Health. 2014 Nov;17(7):A529. doi: 10.1016/j.jval.2014.08.1674. Epub 2014 Oct 26. PMID: 27201676.
Copy Download .nbib Format: NLM
Epidermoid causing ischemic stroke in the brainstem.

Case reports in neurological medicine

Ramdasi R, Mahore A, Kulkarni A, Rangarajan V, Patil M, Kawale J.
PMID: 25580320
Case Rep Neurol Med. 2014;2014:801615. doi: 10.1155/2014/801615. Epub 2014 Dec 15.

Intracranial tumors may rarely cause stroke. We report an epidermoid cyst causing stroke in a pediatric patient. We have also reviewed the literature and pathogenesis of stroke caused by intracranial tumors.

Cite
Ramdasi R, Mahore A, Kulkarni A, et al. Epidermoid causing ischemic stroke in the brainstem. Case Rep Neurol Med. 2014;2014:801615doi: 10.1155/2014/801615.
Ramdasi, R., Mahore, A., Kulkarni, A., Rangarajan, V., Patil, M., & Kawale, J. (2014). Epidermoid causing ischemic stroke in the brainstem. Case reports in neurological medicine, 2014801615. https://doi.org/10.1155/2014/801615
Ramdasi, Raghvendra, et al. "Epidermoid causing ischemic stroke in the brainstem." Case reports in neurological medicine vol. 2014 (2014): 801615. doi: https://doi.org/10.1155/2014/801615
Ramdasi R, Mahore A, Kulkarni A, Rangarajan V, Patil M, Kawale J. Epidermoid causing ischemic stroke in the brainstem. Case Rep Neurol Med. 2014;2014:801615. doi: 10.1155/2014/801615. Epub 2014 Dec 15. PMID: 25580320; PMCID: PMC4279849.
Copy Download .nbib Format: NLM
Brain Herniation in Neurofibromatosis with Dysplasia of Occipital Bone and Posterior Skull Base.

Case reports in neurological medicine

Rangarajan V, Mahore A, Patil M, Sathe P, Kaswa A, Gore S, Dharurkar P, Kawale J.
PMID: 26600957
Case Rep Neurol Med. 2015;2015:816079. doi: 10.1155/2015/816079. Epub 2015 Oct 27.

A 22-year-old female, a known case of neurofibromatosis 1 (NF1), presented with a congenital swelling in the left occipital region. She had developed recent onset dysphagia and localized occipital headache. Neuroradiology revealed a left occipital meningoencephalocele and a left...

Cite
Rangarajan V, Mahore A, Patil M, et al. Brain Herniation in Neurofibromatosis with Dysplasia of Occipital Bone and Posterior Skull Base. Case Rep Neurol Med. 2015;2015:816079doi: 10.1155/2015/816079.
Rangarajan, V., Mahore, A., Patil, M., Sathe, P., Kaswa, A., Gore, S., Dharurkar, P., & Kawale, J. (2015). Brain Herniation in Neurofibromatosis with Dysplasia of Occipital Bone and Posterior Skull Base. Case reports in neurological medicine, 2015816079. https://doi.org/10.1155/2015/816079
Rangarajan, Vithal, et al. "Brain Herniation in Neurofibromatosis with Dysplasia of Occipital Bone and Posterior Skull Base." Case reports in neurological medicine vol. 2015 (2015): 816079. doi: https://doi.org/10.1155/2015/816079
Rangarajan V, Mahore A, Patil M, Sathe P, Kaswa A, Gore S, Dharurkar P, Kawale J. Brain Herniation in Neurofibromatosis with Dysplasia of Occipital Bone and Posterior Skull Base. Case Rep Neurol Med. 2015;2015:816079. doi: 10.1155/2015/816079. Epub 2015 Oct 27. PMID: 26600957; PMCID: PMC4639658.
Copy Download .nbib Format: NLM
Corrigendum: Proteogenomic integration reveals therapeutic targets in breast cancer xenografts.

Nature communications

Huang KL, Li S, Mertins P, Cao S, Gunawardena HP, Ruggles KV, Mani DR, Clauser KR, Tanioka M, Usary J, Kavuri SM, Xie L, Yoon C, Qiao JW, Wrobel J, Wyczalkowski MA, Erdmann-Gilmore P, Snider JE, Hoog J, Singh P, Niu B, Guo Z, Sun SQ, Sanati S, Kawaler E, Wang X, Scott A, Ye K, McLellan MD, Wendl MC, Malovannaya A, Held JM, Gillette MA, Fenyö D, Kinsinger CR, Mesri M, Rodriguez H, Davies SR, Perou CM, Ma C, Townsend RR, Chen X, Carr SA, Ellis MJ, Ding L.
PMID: 28440318
Nat Commun. 2017 Apr 25;8:15479. doi: 10.1038/ncomms15479.

No abstract available.

Cite
Huang KL, Li S, Mertins P, et al. Corrigendum: Proteogenomic integration reveals therapeutic targets in breast cancer xenografts. Nat Commun. 2017;8:15479doi: 10.1038/ncomms15479.
Huang, K. L., Li, S., Mertins, P., Cao, S., Gunawardena, H. P., Ruggles, K. V., Mani, D. R., Clauser, K. R., Tanioka, M., Usary, J., Kavuri, S. M., Xie, L., Yoon, C., Qiao, J. W., Wrobel, J., Wyczalkowski, M. A., Erdmann-Gilmore, P., Snider, J. E., Hoog, J., Singh, P., Niu, B., Guo, Z., Sun, S. Q., Sanati, S., Kawaler, E., Wang, X., Scott, A., Ye, K., McLellan, M. D., Wendl, M. C., Malovannaya, A., Held, J. M., Gillette, M. A., Fenyö, D., Kinsinger, C. R., Mesri, M., Rodriguez, H., Davies, S. R., Perou, C. M., Ma, C., Townsend, R. R., Chen, X., Carr, S. A., Ellis, M. J., & Ding, L. (2017). Corrigendum: Proteogenomic integration reveals therapeutic targets in breast cancer xenografts. Nature communications, 815479. https://doi.org/10.1038/ncomms15479
Huang, Kuan-Lin, et al. "Corrigendum: Proteogenomic integration reveals therapeutic targets in breast cancer xenografts." Nature communications vol. 8 (2017): 15479. doi: https://doi.org/10.1038/ncomms15479
Huang KL, Li S, Mertins P, Cao S, Gunawardena HP, Ruggles KV, Mani DR, Clauser KR, Tanioka M, Usary J, Kavuri SM, Xie L, Yoon C, Qiao JW, Wrobel J, Wyczalkowski MA, Erdmann-Gilmore P, Snider JE, Hoog J, Singh P, Niu B, Guo Z, Sun SQ, Sanati S, Kawaler E, Wang X, Scott A, Ye K, McLellan MD, Wendl MC, Malovannaya A, Held JM, Gillette MA, Fenyö D, Kinsinger CR, Mesri M, Rodriguez H, Davies SR, Perou CM, Ma C, Townsend RR, Chen X, Carr SA, Ellis MJ, Ding L. Corrigendum: Proteogenomic integration reveals therapeutic targets in breast cancer xenografts. Nat Commun. 2017 Apr 25;8:15479. doi: 10.1038/ncomms15479. PMID: 28440318; PMCID: PMC5414030.
Copy Download .nbib Format: NLM
WITHDRAWN: Effect of Vibram FiveFingers Minimalist Shoes on the Abductor Hallucis Muscle.

Journal of the American Podiatric Medical Association

Campitelli NA, Bernhard KN, Kidon A, Heard K, Spencer SA, Kawalec JS.
PMID: 26247239
J Am Podiatr Med Assoc. 2015 Sep 21; doi: 10.7547/14-084.1. Epub 2015 Sep 21.

Ahead of Print article withdrawn by publisher.

Cite
Campitelli NA, Bernhard KN, Kidon A, et al. WITHDRAWN: Effect of Vibram FiveFingers Minimalist Shoes on the Abductor Hallucis Muscle. J Am Podiatr Med Assoc. 2015;doi: 10.7547/14-084.1.
Campitelli, N. A., Bernhard, K. N., Kidon, A., Heard, K., Spencer, S. A., & Kawalec, J. S. (2015). WITHDRAWN: Effect of Vibram FiveFingers Minimalist Shoes on the Abductor Hallucis Muscle. Journal of the American Podiatric Medical Association, . https://doi.org/10.7547/14-084.1
Campitelli, N A, et al. "WITHDRAWN: Effect of Vibram FiveFingers Minimalist Shoes on the Abductor Hallucis Muscle." Journal of the American Podiatric Medical Association vol. (2015). doi: https://doi.org/10.7547/14-084.1
Campitelli NA, Bernhard KN, Kidon A, Heard K, Spencer SA, Kawalec JS. WITHDRAWN: Effect of Vibram FiveFingers Minimalist Shoes on the Abductor Hallucis Muscle. J Am Podiatr Med Assoc. 2015 Sep 21; doi: 10.7547/14-084.1. Epub 2015 Sep 21. PMID: 26247239.
Copy Download .nbib Format: NLM
Tumor necrosis factor-α antibodies (infliximab, adalimumab and certolizumab) in Crohn's disease: systematic review and meta-analysis.

Archives of medical science : AMS

Kawalec P, Mikrut A, Wiśniewska N, Pilc A.
PMID: 24273556
Arch Med Sci. 2013 Oct 31;9(5):765-79. doi: 10.5114/aoms.2013.38670. Epub 2013 Nov 05.

INTRODUCTION: This meta-analysis compares the effectiveness and safety of tumor necrosis factor α (TNF-α) antibodies (infliximab, adalimumab and certolizumab) with either a placebo or each of them in the treatment of Crohn's disease (CD).MATERIAL AND METHODS: A systematic review...

Cite
Kawalec P, Mikrut A, Wiśniewska N, et al. Tumor necrosis factor-α antibodies (infliximab, adalimumab and certolizumab) in Crohn's disease: systematic review and meta-analysis. Arch Med Sci. 2013;9(5):765-79doi: 10.5114/aoms.2013.38670.
Kawalec, P., Mikrut, A., Wiśniewska, N., & Pilc, A. (2013). Tumor necrosis factor-α antibodies (infliximab, adalimumab and certolizumab) in Crohn's disease: systematic review and meta-analysis. Archives of medical science : AMS, 9(5), 765-79. https://doi.org/10.5114/aoms.2013.38670
Kawalec, Paweł, et al. "Tumor necrosis factor-α antibodies (infliximab, adalimumab and certolizumab) in Crohn's disease: systematic review and meta-analysis." Archives of medical science : AMS vol. 9,5 (2013): 765-79. doi: https://doi.org/10.5114/aoms.2013.38670
Kawalec P, Mikrut A, Wiśniewska N, Pilc A. Tumor necrosis factor-α antibodies (infliximab, adalimumab and certolizumab) in Crohn's disease: systematic review and meta-analysis. Arch Med Sci. 2013 Oct 31;9(5):765-79. doi: 10.5114/aoms.2013.38670. Epub 2013 Nov 05. PMID: 24273556; PMCID: PMC3832823.
Copy Download .nbib Format: NLM
Influence of Y2BaCuO5 particles on the microstructure of YBa2Cu3O7-x (123)-Y2BaCuO5 (211) melt-textured superconductors.

Physical review. B, Condensed matter

Diko P, Gawalek W, Görnert P, Habisreuther T, Klupsch T.
PMID: 9980566
Phys Rev B Condens Matter. 1995 Nov 01;52(18):13658-13664. doi: 10.1103/physrevb.52.13658.

No abstract available.

Cite
Diko P, Gawalek W, Görnert P, et al. Influence of Y2BaCuO5 particles on the microstructure of YBa2Cu3O7-x (123)-Y2BaCuO5 (211) melt-textured superconductors. Phys Rev B Condens Matter. 1995;52(18):13658-13664doi: 10.1103/physrevb.52.13658.
Diko, P., Gawalek, W., Görnert, P., Habisreuther, T., & Klupsch, T. (1995). Influence of Y2BaCuO5 particles on the microstructure of YBa2Cu3O7-x (123)-Y2BaCuO5 (211) melt-textured superconductors. Physical review. B, Condensed matter, 52(18), 13658-13664. https://doi.org/10.1103/physrevb.52.13658
Diko, et al. "Influence of Y2BaCuO5 particles on the microstructure of YBa2Cu3O7-x (123)-Y2BaCuO5 (211) melt-textured superconductors." Physical review. B, Condensed matter vol. 52,18 (1995): 13658-13664. doi: https://doi.org/10.1103/physrevb.52.13658
Diko P, Gawalek W, Görnert P, Habisreuther T, Klupsch T. Influence of Y2BaCuO5 particles on the microstructure of YBa2Cu3O7-x (123)-Y2BaCuO5 (211) melt-textured superconductors. Phys Rev B Condens Matter. 1995 Nov 01;52(18):13658-13664. doi: 10.1103/physrevb.52.13658. PMID: 9980566.
Copy Download .nbib Format: NLM
Relationship between physician-based assessment of disease activity, quality of life, and costs of ulcerative colitis in Poland.

Przeglad gastroenterologiczny

Kawalec P, Stawowczyk E.
PMID: 29657613
Prz Gastroenterol. 2018;13(1):61-68. doi: 10.5114/pg.2018.74568. Epub 2018 Mar 26.

INTRODUCTION: Ulcerative colitis (UC) is an idiopathic inflammatory bowel disorder, which requires lifelong treatment. It generates substantial direct and indirect costs, and significantly affects the quality of life, especially in the active state of the disease.AIM: To evaluate the...

Cite
Kawalec P, Stawowczyk E. Relationship between physician-based assessment of disease activity, quality of life, and costs of ulcerative colitis in Poland. Prz Gastroenterol. 2018;13(1):61-68doi: 10.5114/pg.2018.74568.
Kawalec, P., & Stawowczyk, E. (2018). Relationship between physician-based assessment of disease activity, quality of life, and costs of ulcerative colitis in Poland. Przeglad gastroenterologiczny, 13(1), 61-68. https://doi.org/10.5114/pg.2018.74568
Kawalec, Paweł, and Stawowczyk, Ewa. "Relationship between physician-based assessment of disease activity, quality of life, and costs of ulcerative colitis in Poland." Przeglad gastroenterologiczny vol. 13,1 (2018): 61-68. doi: https://doi.org/10.5114/pg.2018.74568
Kawalec P, Stawowczyk E. Relationship between physician-based assessment of disease activity, quality of life, and costs of ulcerative colitis in Poland. Prz Gastroenterol. 2018;13(1):61-68. doi: 10.5114/pg.2018.74568. Epub 2018 Mar 26. PMID: 29657613; PMCID: PMC5894454.
Copy Download .nbib Format: NLM
Autophagy modulates temozolomide-induced cell death in alveolar Rhabdomyosarcoma cells.

Cell death discovery

Moghadam AR, da Silva Rosa SC, Samiei E, Alizadeh J, Field J, Kawalec P, Thliveris J, Akbari M, Ghavami S, Gordon JW.
PMID: 30416757
Cell Death Discov. 2018 Oct 25;4:52. doi: 10.1038/s41420-018-0115-9. eCollection 2018.

Rhabdomyosarcoma (RMS) is a muscle-derived tumor. In both pre-clinical and clinical studies Temozolomide (TMZ) has been recently tested against RMS; however, the precise mechanism of action of TMZ in RMS remains unclear. Here we demonstrate that TMZ decreases the...

Cite
Moghadam AR, da Silva Rosa SC, Samiei E, et al. Autophagy modulates temozolomide-induced cell death in alveolar Rhabdomyosarcoma cells. Cell Death Discov. 2018;4:52doi: 10.1038/s41420-018-0115-9.
Moghadam, A. R., da Silva Rosa, S. C., Samiei, E., Alizadeh, J., Field, J., Kawalec, P., Thliveris, J., Akbari, M., Ghavami, S., & Gordon, J. W. (2018). Autophagy modulates temozolomide-induced cell death in alveolar Rhabdomyosarcoma cells. Cell death discovery, 452. https://doi.org/10.1038/s41420-018-0115-9
Moghadam, Adel Rezaei, et al. "Autophagy modulates temozolomide-induced cell death in alveolar Rhabdomyosarcoma cells." Cell death discovery vol. 4 (2018): 52. doi: https://doi.org/10.1038/s41420-018-0115-9
Moghadam AR, da Silva Rosa SC, Samiei E, Alizadeh J, Field J, Kawalec P, Thliveris J, Akbari M, Ghavami S, Gordon JW. Autophagy modulates temozolomide-induced cell death in alveolar Rhabdomyosarcoma cells. Cell Death Discov. 2018 Oct 25;4:52. doi: 10.1038/s41420-018-0115-9. eCollection 2018. PMID: 30416757; PMCID: PMC6202374.
Copy Download .nbib Format: NLM
Cost-effectiveness of biological treatment of ulcerative colitis - a systematic review.

Przeglad gastroenterologiczny

Stawowczyk E, Kawalec P.
PMID: 28702096
Prz Gastroenterol. 2017;12(2):90-97. doi: 10.5114/pg.2017.68166. Epub 2017 Jun 13.

The aim of this systematic review was to collect and summarise all current data on the cost-effectiveness of biological treatment in ulcerative colitis. A literature search was conducted using the Medline, Embase, Centre for Reviews and Dissemination databases and...

Cite
Stawowczyk E, Kawalec P. Cost-effectiveness of biological treatment of ulcerative colitis - a systematic review. Prz Gastroenterol. 2017;12(2):90-97doi: 10.5114/pg.2017.68166.
Stawowczyk, E., & Kawalec, P. (2017). Cost-effectiveness of biological treatment of ulcerative colitis - a systematic review. Przeglad gastroenterologiczny, 12(2), 90-97. https://doi.org/10.5114/pg.2017.68166
Stawowczyk, Ewa, and Kawalec, Paweł. "Cost-effectiveness of biological treatment of ulcerative colitis - a systematic review." Przeglad gastroenterologiczny vol. 12,2 (2017): 90-97. doi: https://doi.org/10.5114/pg.2017.68166
Stawowczyk E, Kawalec P. Cost-effectiveness of biological treatment of ulcerative colitis - a systematic review. Prz Gastroenterol. 2017;12(2):90-97. doi: 10.5114/pg.2017.68166. Epub 2017 Jun 13. PMID: 28702096; PMCID: PMC5497136.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 127 entries